IRMC Wave Down Arrow Icon Oncology Symbol Radiation Oncology Symbol General Icon Hospital Icon Skin Cancer Icon Administration Symbol Contract Icon Expand Icon

Taking care of the patient,
not just the cancer.

3555 10th Court | Vero Beach, FL 32960

Thoracic Cancer (Lung)

Physician Teams

The Thoracic Cancer Team is led by Mark Malias, M.D. The team supports early detection of lung cancer through screening and also has a specialized pulmonary nodule clinic to ensure that the early lesions are appropriately treated. If sampling is required, the team has access to 3D bronchoscopy, equipment that markedly improves accuracy. If lung surgery is necessary, the team also has access to DaVinci Surgical Robot technology that allows for minimally invasive surgery and improved recovery times.

Lung cancer cases are presented at two of the five monthly tumor board conferences. The tumor board conferences are conducted by our physician-based teams at Scully-Welsh Cancer Center. A tumor board is a meeting where complex patient cases are discussed in significant detail by a multidisciplinary team of doctors. The physicians concentrate on patients with difficult tumors or patients who have previously received treatment and, for various reasons, now need a different treatment plan. The doctor teams also review participation in a clinical trial as an option for each patient at the cancer center in Vero Beach. Doctors from each discipline are involved in this meeting and may include nearly a dozen or more cancer experts. Each patient’s diagnosis is introduced, and the group reviews the patient’s scans, biopsies, lab results, and other records with the goal of coming up with the best treatment plan. The team includes other medical oncologists, radiation oncologists, surgical oncology, radiology, interventional radiology, pathology, patient care navigator, nutritionist, and behavioral health specialist.

Patient care coordination for the Brain Cancer Team is arranged through our patient care navigators at (772) 226-4827.

Take Our Lung Cancer Risk Assessment »